These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3391051

  • 1. Susceptibilities of streptococcal strains associated with infective endocarditis to nine antibiotics.
    Etienne J, Coulet M, Brun Y, Blanchon JF, Demoux F, Fleurette J.
    Chemotherapy; 1988; 34(2):113-6. PubMed ID: 3391051
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
    Entenza JM, Caldelari I, Glauser MP, Moreillon P.
    J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
    [Abstract] [Full Text] [Related]

  • 3. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
    Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR.
    Clin Infect Dis; 2001 Aug 15; 33(4):577-9. PubMed ID: 11462199
    [Abstract] [Full Text] [Related]

  • 4. [Endocarditis caused by group D streptococci. Comparison of the antibiotic sensitivity of S. bovis and enterococci].
    Bastin R, Dournon E, Huchon A, Bricaire F, Bure A, Frottier J, Vildé JL.
    Rev Med Interne; 1981 Oct 15; 2(3):257-62. PubMed ID: 6794122
    [No Abstract] [Full Text] [Related]

  • 5. A case of infective endocarditis caused by a viridans group streptococcus resistant to ceftriaxone.
    Black A.
    S Afr Med J; 2001 May 15; 91(5):407. PubMed ID: 11455805
    [No Abstract] [Full Text] [Related]

  • 6. Susceptibilities to ceftriaxone of streptococcal strains associated with infective endocarditis.
    Etienne J, Vandenesch F, Fauvel JP, Coulet M, Brun Y, Fleurette J.
    Chemotherapy; 1989 May 15; 35(5):355-9. PubMed ID: 2791712
    [Abstract] [Full Text] [Related]

  • 7. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
    McWhinney PH, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC.
    Antimicrob Agents Chemother; 1993 Nov 15; 37(11):2493-5. PubMed ID: 8285642
    [Abstract] [Full Text] [Related]

  • 8. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
    Shelburne SA, Greenberg SB, Aslam S, Tweardy DJ.
    J Infect; 2007 Feb 15; 54(2):e99-101. PubMed ID: 16824611
    [Abstract] [Full Text] [Related]

  • 9. Infective endocarditis due to penicillin-tolerant Streptococcus bovis.
    Fung JC, Gadbaw JJ, Donta ST, Tilton RC.
    Diagn Microbiol Infect Dis; 1986 Jul 15; 5(2):171-6. PubMed ID: 3720266
    [Abstract] [Full Text] [Related]

  • 10. Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis.
    Isaksson B, Hanberger H, Maller R, Nilsson LE, Nilsson M.
    J Antimicrob Chemother; 1991 May 15; 27 Suppl C():9-14. PubMed ID: 1906865
    [Abstract] [Full Text] [Related]

  • 11. Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment.
    Mihaila-Amrouche L, Schlegel L, Bouvet A, Association pour l'Etude et la Prévention de l'Endocadite Infectieuse (AEPEI) Study Group.
    Indian J Med Res; 2004 May 15; 119 Suppl():80-3. PubMed ID: 15232168
    [Abstract] [Full Text] [Related]

  • 12. [Enterococci: high level of resistance to aminoglycosides].
    del Valle-Ortiz O, Gallés C, Codina G, Cano A.
    Enferm Infecc Microbiol Clin; 1989 Dec 15; 7(10):535-41. PubMed ID: 2490431
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview.
    Francioli P.
    Eur Heart J; 1995 Apr 15; 16 Suppl B():75-9. PubMed ID: 7671930
    [Abstract] [Full Text] [Related]

  • 14. The changing character of infective endocarditis.
    Quinn EL, Burch KH, Cox F, Fisher E, Madhavan T.
    Am Fam Physician; 1975 Mar 15; 11(3):117-24. PubMed ID: 803764
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH, Leonhard B.
    Chemotherapy; 1997 Mar 15; 43(2):123-31. PubMed ID: 9084921
    [Abstract] [Full Text] [Related]

  • 16. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
    Hsu RB, Lin FY.
    Cardiology; 2006 Mar 15; 105(4):234-9. PubMed ID: 16534200
    [Abstract] [Full Text] [Related]

  • 17. Group G streptococcal septicaemia: clinical observations and laboratory studies.
    Finch RG, Aveline A.
    J Infect; 1984 Sep 15; 9(2):126-33. PubMed ID: 6501901
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT, Pelletier LL, Petersdorf RG.
    J Clin Invest; 1974 Mar 15; 53(3):829-33. PubMed ID: 4492776
    [Abstract] [Full Text] [Related]

  • 19. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
    Fujitani S, Rowlinson MC, George WL.
    Clin Infect Dis; 2008 Apr 01; 46(7):1064-6. PubMed ID: 18444825
    [Abstract] [Full Text] [Related]

  • 20. Susceptibilities of enterococci to twelve antibiotics.
    Tofte RW, Solliday JA, Crossley KB.
    Antimicrob Agents Chemother; 1984 Apr 01; 25(4):532-3. PubMed ID: 6428309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.